B

Biovaxys Technology Corp
OTC:BVAXF

Watchlist Manager
Biovaxys Technology Corp
OTC:BVAXF
Watchlist
Price: 0.2 USD 12.42% Market Closed
Market Cap: 44m USD

Intrinsic Value

BVAXF doesn't have a meaningful market cap.

The intrinsic value of one BVAXF stock under the Base Case scenario is 0.003 USD. Compared to the current market price of 0.2 USD, Biovaxys Technology Corp is Overvalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BVAXF Intrinsic Value
0.003 USD
Overvaluation 99%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
Biovaxys Technology Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about BVAXF?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BVAXF valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Biovaxys Technology Corp.

Explain Valuation
Compare BVAXF to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BIOV?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biovaxys Technology Corp

Current Assets 1.4m
Cash & Short-Term Investments 4.1k
Receivables 486.8k
Other Current Assets 895.7k
Current Liabilities 5m
Accounts Payable 2.5m
Accrued Liabilities 249.8k
Short-Term Debt 133.7k
Other Current Liabilities 2.2m
Efficiency

Free Cash Flow Analysis
Biovaxys Technology Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biovaxys Technology Corp

Revenue
0 CAD
Operating Expenses
-4.9m CAD
Operating Income
-4.9m CAD
Other Expenses
-1.1m CAD
Net Income
-6m CAD
Fundamental Scores

BVAXF Profitability Score
Profitability Due Diligence

Biovaxys Technology Corp's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional ROE
76/100
Profitability
Score

Biovaxys Technology Corp's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

BVAXF Solvency Score
Solvency Due Diligence

Biovaxys Technology Corp's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
30/100
Solvency
Score

Biovaxys Technology Corp's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BVAXF Price Targets Summary
Biovaxys Technology Corp

There are no price targets for BVAXF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Biovaxys Technology Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for BIOV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BVAXF stock?

The intrinsic value of one BVAXF stock under the Base Case scenario is 0.003 USD.

Is BVAXF stock undervalued or overvalued?

Compared to the current market price of 0.2 USD, Biovaxys Technology Corp is Overvalued by 99%.

Back to Top